An assessment of the economic burden of senile chronic diseases in China based on China Health and Retirement Longitudinal Survey.,Expert Review of Pharmacoeconomics & Outcomes Research

当前位置： X-MOL 学术 › Expert Rev. Pharmacoecon. Outcomes Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

An assessment of the economic burden of senile chronic diseases in China based on China Health and Retirement Longitudinal Survey.
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2019-11-05 , DOI: 10.1080/14737167.2020.1688661
Xiayan Dong ₁ , Linhong Chen _{2,

3} , Zhiming Xu ₄ , Xiaocang Xu ₅

Affiliation

Objective: This study assessed the economic burden of senile chronic diseases (SCD) in China.Methods: Based on China Health and Retirement Longitudinal Survey data, we used propensity score matching to compare the economic burden of SCD for families with and without members with SCD.Results: We examined three aspects of economic burden: health service utilization, including health care utilization and expenditure, family daily consumption spending, and workforce participation of family members in labor markets. SCD-families showed a higher hospitalization rate and number of outpatient visits than the control group. SCD-families also consumed less per capita. Additionally, the negative influence of SCD on total family income may be partially offset by increasing the labor force participation rate of healthy family members. Finally, we also discussed the burden of SCD in different educational status.Conclusions: Relevant results may provide insight into formulating health and labor policies by the Chinese government. The study significance consists of the selection of matching variables and robustness, whereas study limitations include the omission of other important variables.

更新日期：2019-11-05

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>